The increasing use of AI in clinical research raises the question of how patients and the public should be involved in its development and use. Christine Jacob from the European Patients’ Academy on Therapeutic Innovation Switzerland (EUPATI CH) explore the role of patients and the public in the development and use of AI in clinical research. She highlights how their involvement can help ensure that AI technologies deliver meaningful, trustworthy value in real-world research settings.